Profitelligence Profitelligence · Filing Ledger Open TMO research →

Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-11

Shafer Michael D Files Thermo Fisher Scientific (TMO) Form 4 - August 11, 2026

Shafer Michael D traded 51.0K TMO shares worth $24.7M in this Form 4 filing, reported to the SEC on 2026-08-11.

Issuer
Thermo Fisher Scientific Inc. TMO · NYSE
Filed
Period
2026-08-11
Accession
0000097745-26-000149

Transactions (6)

Insider Date Type Shares Price Value Own
Shafer Michael D 2026-08-11 Buy 11.2K $309.63 $3.5M Direct
Shafer Michael D 2026-08-11 Sell 11.2K $600.00 $6.7M Direct
Shafer Michael D 2026-08-11 Buy 14.3K $418.32 $6.0M Direct
Shafer Michael D 2026-08-11 Sell 14.3K $600.00 $8.6M Direct
Net change0−$5.9M

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Track TMO insider activity

Get alerted when Thermo Fisher Scientific Inc. executives buy or sell their shares.

Set up free alerts